65,437 trials
Whole Genome Sequencing
Primary: Evaluate Parental Empowerment Using the Genetic Counseling Outcome Scale (GCOS) — 117.94; 117.19 score on a scale
Heavy Drinking · Harmful; Use, Alcohol
Primary: Total Drinks Consumed — 6.76; 7.07 drinks — p=<0.0001
Breast Cancer · Estrogen Receptor Positive Tumor · HER2-positive Breast Cancer
Primary: Pathological Complete Response (pCR) — 24; 24 Participants
Parkinson Disease
Primary: Assessment of the Effectiveness of Two Months of Use of the Remedee Endorphin Band Medical Device in Improving Motor Disorders in Patients With Parkinson's Disease — 6…
HIV Infections
Primary: Undetectable Viral Load — 58.8; 62.9; 89.5; 87.5 percentage of participants
Chikungunya Virus
Primary: Anti-CHIKV SNA Titer (NT80) Seroresponse Rates at Day 22 in Baseline Seronegative Participants — 87.3; 1.1 percentage of participants — p=<0.0001
Developmental Language Disorder
Primary: Mean Percent Correct Semantic Meaning Identification — 73.6; 75.12; 77.1; 82.3 percentage of correct responses — p=0.36
Idiopathic Pulmonary Fibrosis
Primary: Number of Participants With Treatment-emergent (TE) Serious Adverse Events (SAEs) — 5; 2 Participants
Breast Cancer
Primary: Mammogram Intention — 1.90 score on a scale
Type 2 Diabetes · Diabetes Mellitus, Type 2
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) — -0.43 Percentage of HbA1c
Cerebral Palsy · Central Nervous System Diseases · Brain Damage, Chronic
Primary: Change in Self-selected Gait Speed (Normalized) — -0.0010; 0.0163 dimensionless
Hypertriglyceridemia · Inflammation · Waist, Hypertriglyceridemic
Primary: Change in Postprandial Serum Triglyceride — -0.1; 0.2 mmol*hr/L
Acute Myeloid Leukemia · Myelodysplastic Syndrome
Primary: Overall Response Rate (ORR) in Biomarker Positive AML or HR-MDS Participants Treated With Tamibarotene Monotherapy or in Combination With Azacitidine — 2; 0; 4; 12…
Hypoxia
Primary: Measure of Accuracy (ARMS [%]) — 2.95 Percentage
Diet Modification · Cognitive Decline · Cognitive Change
Primary: Change in Mean Global Composite Cognition Score From Baseline — 0.2; 0.2 Z-score — p=0.259